Our results suggested that altered signaling and expression of c-kit/SCF, c-myc and STAT3 in NK cells from cancer patients was responsible for the defect in NK cell cytolytic activity seen in many patients and that these abnormalities in the gene expression may be the cause rather than the result of tumor progression. This evidence concerns the gene MYC and neoplasm.